Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Dermatology Research and Practice|May 16, 2020
Onychomycosis in Psoriatic Patients with Nail Disorders: Aetiological Agents and Immunosuppressive TherapyNúbia Carvalho Pena de Oliveira Praeiro Alves, Tomaz de Aquino Moreira, Lucivânia Duarte Silva Malvino, et al.
Arthritis Research & Therapy|April 10, 2023
Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studiesXenofon Baraliakos, Roberto Ranza, Andrew Östör, et al.
Patient Preference and Adherence|July 2, 2020
Treatment Mode Preferences in Psoriatic Arthritis: A Qualitative Multi-Country StudyDaniel Aletaha, M Elaine Husni, Joseph F Merola, et al.
Advances in Rheumatology (London, England)|September 23, 2020
Validation and clinical interpretability of PsAID - psoriatic arthritis impact of diseaseElziane da Cruz Ribeiro E Souza, Sueli Coelho da Silva Carneiro, Michel Alexandre Yazbek, et al.
The Journal of Rheumatology|March 3, 2015
Prevalence of psoriatic arthritis in a large cohort of Brazilian patients with psoriasisRoberto Ranza, Sueli Carneiro, Abrar A Qureshi, et al.
Plos One|October 12, 2018
Semantic and psychometric validation of the Brazilian Portuguese version (PASE-P) of the Psoriatic Arthritis Screening and Evaluation questionnaireCarolina Zorzanelli Costa, Claudia Goldenstein-Schainberg, Sueli Carneiro, et al.
Revista Brasileira De Reumatologia|May 18, 2011
Brazilian biologic registry: BiobadaBrasil implementation process and preliminary resultsDavid C Titton, Ines Guimarães Silveira, Paulo Louzada-Junior, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 20, 2020
Incidence of Infectious Adverse Events in Patients With Rheumatoid Arthritis and Spondyloarthritis on Biologic Drugs-Data From the Brazilian Registry for Biologics MonitoringMariana Cecconi, Roberto Ranza, David C Titton, et al.
Pageof 3